Leucine zipper-based compositions and methods of use
US-12509498-B2 · Dec 30, 2025 · US
IL-3
IL-3 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/5403 |
| Official title | {IL-3} |
| Display label | IL-3 |
| Total patents | 64 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Methods and models for assessing efficacy of immunotherapies
US-12409237-B1 · Sep 9, 2025 · US
Genetically modified mice and engraftment
US-12402611-B2 · Sep 2, 2025 · US
Vectors, genetically modified cells, and genetically modified non-human animals comprising the same
US-2025255282-A1 · Aug 14, 2025 · US
Chimeric antigen receptor modified regulatory t cells for treating cancer
US-2025235478-A1 · Jul 24, 2025 · US
Genetically Modified Non-Human Animals And Methods Of Use Thereof
US-2025072405-A1 · Mar 6, 2025 · US
Genetically modified non-human animals and methods of use thereof
US-12127537-B2 · Oct 29, 2024 · US
Bispecific binding agent-ligand fusions for the degradation of target proteins
US-2024189423-A1 · Jun 13, 2024 · US
Chimeric opsin gpcr proteins
US-2024174743-A1 · May 30, 2024 · US
Astrocyte Interleukin-3 Reprograms Microglia and Limits Alzheimer`s Disease
US-2024148832-A1 · May 9, 2024 · US
Genetically modified non-human animals and methods of use thereof
US-2024099278-A1 · Mar 28, 2024 · US
Vectors, genetically modified cells, and genetically modified non-human animals comprising the same
US-2024102045-A1 · Mar 28, 2024 · US
Genetically modified non-human animals expressing human epo
US-2024074414-A1 · Mar 7, 2024 · US
Genetically modified non-human animals and methods of use thereof
US-11778995-B2 · Oct 10, 2023 · US
Genetically modified non-human animals expressing human EPO
US-11766032-B2 · Sep 26, 2023 · US
Transgenic mouse model expressing human hla-a201 restriction gene
US-2023270085-A1 · Aug 31, 2023 · US
Peptide for suppressing osteoclast differentiation and use thereof
US-11512112-B2 · Nov 29, 2022 · US
Compositions and methods for expansion of embryonic hematopoietic stem cells
US-11439667-B2 · Sep 13, 2022 · US
Human-CD123-targeting chimeric receptor ligand and application thereof
US-11401317-B2 · Aug 2, 2022 · US
Genetically Modified Mice and Engraftment
US-2022000084-A1 · Jan 6, 2022 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/5403?
- CPC C07K14/5403 is the Cooperative Patent Classification code for “IL-3.”
- How many patents are filed under CPC C07K14/5403 (IL-3)?
- Our database includes 64 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/5403 growing?
- Publication counts under this code: 7 in 2024 vs 6 in 2025 (latest complete years).